[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370590-105":59,"doc-detail-370590-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","characteristics-of-18-f-fapi-04-petct-in-patients-with-peritoneal-metastasis-to-predict-treatment-efficacy-a-head-to-head-comparison-with-18-f-fdg-petct","Characteristics of 18 F-FAPI-04 PET/CT in Patients with Peritoneal Metastasis - to Predict Treatment Efficacy - a Head-to-Head Comparison with 18 F-FDG PET/CT","","18 F-FAPI-04 PET/CT offers promise for detecting peritoneal metastases, yet its advantage over 18 F-FDG PET/CT for lesion detection and for predicting chemotherapy benefit remains uncertain. This study compared imaging features between both tracers in 39 patients with pathologically confirmed peritoneal metastases, analyzing semi-quantitative PET parameters, tracer uptake relationships with FAP and α-SMA, and treatment response using RECIST and logistic regression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characteristics-of-18-f-fapi-04-petct-in-patients-with-peritoneal-metastasis-to-predict-treatment-efficacy-a-head-to-head-comparison-with-18-f-fdg-petct/370590/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characteristics-of-18-f-fapi-04-petct-in-patients-with-peritoneal-metastasis-to-predict-treatment-efficacy-a-head-to-head-comparison-with-18-f-fdg-petct/370590.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn Holloway","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main goal of comparing 18 F-FAPI-04 and 18 F-FDG PET/CT?","Question",{"text":113,"@type":114},"To compare imaging features of 18 F-FAPI-04 and 18 F-FDG PET/CT in peritoneal metastasis and evaluate the predictive value of 18 F-FAPI-04 for chemotherapy efficacy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients and PET/CT scans handled in the study?",{"text":118,"@type":114},"Thirty-nine patients with pathologically confirmed peritoneal metastases underwent concurrent 18 F-FAPI-04 and 18 F-FDG PET/CT, followed by analysis of semi-quantitative parameters.",{"name":120,"@type":111,"acceptedAnswer":121},"Which 18 F-FAPI-04 PET parameter best predicted chemotherapy response?",{"text":122,"@type":114},"Univariate and multivariate analyses identified 18 F-FAPI-04 SUVmax as an independent predictor of responders versus non-responders.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370590,1790291140,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Zhang et al. Cancer Imaging (2025) 25:66 [https://doi.org/10.1186/s40644-025-00887-9](https://doi.org/10.1186/s40644-025-00887-9)  \nCancer Imaging  \nRESEARCH Open Access  \nCharacteristics of 18 F-FAPI-04 PET/CT  in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18 F-FDG PET/CT  \nYafei Zhang 1†, Mimi Xu 1†, Yu Wang2, Fang Yu3, Xinxin Chen 1, Guangfa Wang 1, Kui Zhao 1, Hong Yang4* and Xinhui Su 1*  \nAbstract  \nBackground 18 F-FAPI-04 PET/CT shows promise in detecting peritoneal metastases (PM), but its superiority over 18 FFDG PET/CT for lesion detection and predicting chemotherapy benefit remains unclear.  \nPurpose To compare 18 F-FAPI-04 and 18 F-FDG PET/CT imaging features in PM and assess predictive value of 18 F-FAPI-04 for chemotherapy efficacy.  \nMethods 39 pathologically confirmed PM patients with digestive malignancies underwent concurrent 18 F-FAPI-04 and 18 F-FDG PET/CT. Semi-quantitative parameters, including SUVmax, tumor/liver ratio (T/L), tumor/mediastinal blood pool ratio (T/B), were analyzed. The tracer uptake was compared via Wilcoxon tests. The relationships between 18 F-FAPI-04 uptake with FAP and α-SMA expression were analyzed using Pearson correlation. Patients were divided into different short-term outcome groups (responders vs. non-responders) according to RECIST criteria (v.1. 1) after chemotherapy. Post-chemotherapy outcomes were evaluated using logistic regression.  \nResults Patients (median age 62; 16 females, 23 males) included pancreatic (n = 17), cholangiocarcinoma (n = 8), gastric (n = 6), and colorectal cancers (n = 8) . 18 F-FAPI-04 demonstrated significantly higher SUVmax, T/L, and T/B than 18 F-FDG (P \u003C 0. 05) . Pancreaticobiliary cancers (pancreatic/cholangiocarcinoma) exhibited higher 18F-FAPI-04 uptake than gastroenteric cancers (gastric/colorectal) (P \u003C 0. 05), though no differences existed within subgroups. 18 F-FAPI-04 parameters positively correlated with FAP and α-SMA expression. In univariate analysis, 18 F-FAPI-04 uptake differed significantly between responders and non-responders. Multivariate analysis identified SUVmax as an independent predictor (OR = 1 . 354, 95%CI:1 .025–1. 788, P = 0 . 033) . Optimal 18 F-FAPI-04 cut-offs for distinguishing outcomes were SUVmax=11.05 (AUC = 0.783; sensitivity = 70.60%, specificity = 80.40%), T/L = 7.53 (AUC = 0.717; 58.82%, 81.82%), and T/B = 8.76 (AUC = 0 . 751; 64 . 71%, 86 . 37%) .  \n†Yafei Zhang and Mimi Xu are contributed equally.  \n*Correspondence: Hong Yang [1307017@zju.edu.cn](1307017@zju.edu.cn)[ ](1307017@zju.edu.cn)Xinhui Su [suxinhui@zju.edu.cn](suxinhui@zju.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nZhang et al. Cancer Imaging (2025) 25:66 Page 2 of 12  \nConclusion 18 F-FAPI-04 PET/CT outp","cbCair9gIngJRZxm","https://ap.wps.com/l/cbCair9gIngJRZxm","pdf",3228861,12,"English","# Abstract\n## Background\n## Purpose\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Background\n## Clinical need for improved detection and prognosis prediction\n## Role and limitations of 18F-FDG PET/CT","[{\"question\":\"What was the main goal of comparing 18 F-FAPI-04 and 18 F-FDG PET/CT?\",\"answer\":\"To compare imaging features of 18 F-FAPI-04 and 18 F-FDG PET/CT in peritoneal metastasis and evaluate the predictive value of 18 F-FAPI-04 for chemotherapy efficacy.\"},{\"question\":\"How were patients and PET/CT scans handled in the study?\",\"answer\":\"Thirty-nine patients with pathologically confirmed peritoneal metastases underwent concurrent 18 F-FAPI-04 and 18 F-FDG PET/CT, followed by analysis of semi-quantitative parameters.\"},{\"question\":\"Which 18 F-FAPI-04 PET parameter best predicted chemotherapy response?\",\"answer\":\"Univariate and multivariate analyses identified 18 F-FAPI-04 SUVmax as an independent predictor of responders versus non-responders.\"}]","Characteristics of 18 F-FAPI-04 PET/CT in Patients with Peritoneal Metastasis - to Predict Treatment Efficacy - a Head-to-Head Comparison with 18 F-FDG PET/CT | PDF",1790189380,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df724b4bee9731b065d581e765261c44.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0db5824e9929a41e7f7c4996b3cf39cd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c92e0dfe941b9619e9adbc1fe27e41e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c4f0ef0bc6eee433d7fabc68ffed11a.webp",980,1306]